Howe & Rusling Inc Abb Vie Inc. Transaction History

Howe & Rusling Inc

$1.16 Billion
Q4 2024

A detailed history of Howe & Rusling Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Howe & Rusling Inc holds 83,647 shares of ABBV stock, worth $15.7 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

83,647

Previous 73,277 14.15%

Holding current value

$15.7 Million

Previous $14.5 Million 2.72%

% of portfolio

1.29%

Previous 1.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$164.99 - $203.87 $1.71 Million - $2.11 Million	10,370 Added 14.15%	83,647 $14.9 Million
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $1.67 Million - $2.03 Million	10,205 Added 16.18%	73,277 $14.5 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $364,685 - $425,870	2,356 Added 3.88%	63,072 $10.8 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $508,707 - $579,624	3,183 Added 5.53%	60,716 $11.1 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $172,000 - $193,712	-1,250 Reduced 2.13%	57,533 $8.92 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $7.55 Million - $8.74 Million	56,528 Added 2506.78%	58,783 $8.76 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $6,625 - $8,245	50 Added 2.27%	2,255 $303,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $33,694 - $38,803	-233 Reduced 9.56%	2,205 $351,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $81,464 - $97,697	-589 Reduced 19.46%	2,438 $394,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $69,118 - $79,273	515 Added 20.5%	3,027 $406,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $68,534 - $87,130	498 Added 24.73%	2,512 $385,000
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $14,913 - $18,503	-113 Reduced 5.31%	2,014 $326,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $107 - $135	-1 Reduced 0.05%	2,127 $288,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1,596 - $1,811	15 Added 0.71%	2,128 $230,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $8,837 - $9,845	84 Added 4.14%	2,113 $238,000
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $7,979 - $8,784	-78 Reduced 3.7%	2,029 $220,000
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $25,917 - $34,991	322 Added 18.04%	2,107 $226,000
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $31,182 - $41,726	425 Added 31.25%	1,785 $175,000
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $9,675 - $14,668	-150 Reduced 9.93%	1,360 $104,000
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $869,527 - $1.09 Million	-12,055 Reduced 88.87%	1,510 $134,000
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $4,975 - $5,981	79 Added 0.59%	13,565 $1.03 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $206,823 - $264,369	-3,148 Reduced 18.93%	13,486 $981,000
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $30,161 - $35,498	-391 Reduced 2.3%	16,634 $1.34 Million
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $13,000 - $16,033	167 Added 0.99%	17,025 $1.57 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $78,418 - $87,176	-882 Reduced 4.97%	16,858 $1.59 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $1 Million - $1.18 Million	-11,153 Reduced 38.6%	17,740 $1.64 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $7.9 Million - $10.6 Million	-85,826 Reduced 74.81%	28,893 $2.74 Million
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $432,485 - $474,256	-4,829 Reduced 4.04%	114,719 $11.1 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $8.35 Million - $10.7 Million	119,548	119,548 $10.6 Million

Others Institutions Holding ABBV

# of Institutions

4,267

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $331B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account